These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29238581)

  • 1. A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus-A case report and review of the literature.
    Babi MA; Robinson CP; Maciel CB
    SAGE Open Med Case Rep; 2017; 5():2050313X17745206. PubMed ID: 29238581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Status Epilepticus and Transient Stress Cardiomyopathy Associated with Smoking the Synthetic Psychoactive Cannabinoid, UR-144.
    Al Fawaz S; Al Deeb M; Huffman JL; Al Kholaif NA; Garlich F; Chuang R
    Am J Case Rep; 2019 Dec; 20():1902-1906. PubMed ID: 31857571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural (∆
    Malyshevskaya O; Aritake K; Kaushik MK; Uchiyama N; Cherasse Y; Kikura-Hanajiri R; Urade Y
    Sci Rep; 2017 Sep; 7(1):10516. PubMed ID: 28874764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The secret "spice": an undetectable toxic cause of seizure.
    de Havenon A; Chin B; Thomas KC; Afra P
    Neurohospitalist; 2011 Oct; 1(4):182-6. PubMed ID: 23983854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute intoxication caused by a synthetic cannabinoid in two adolescents.
    Heath TS; Burroughs Z; Thompson AJ; Tecklenburg FW
    J Pediatr Pharmacol Ther; 2012 Apr; 17(2):177-81. PubMed ID: 23118671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB
    Funada M; Takebayashi-Ohsawa M
    Toxicol Appl Pharmacol; 2018 Jan; 338():1-8. PubMed ID: 29042214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report.
    Alhassan A; Prahad SR; Burk BG; Fargason RE; Birur B
    Psychopharmacol Bull; 2024 Mar; 54(1):33-39. PubMed ID: 38449474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convulsions associated with the use of a synthetic cannabinoid product.
    Schneir AB; Baumbacher T
    J Med Toxicol; 2012 Mar; 8(1):62-4. PubMed ID: 22160733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Liver Injury Induced by Synthetic Cannabinoid Abuse.
    Shahbaz A; Gaviria REE; Shahid MF; Yasin MA; Ashraf A; Zaman MA
    Cureus; 2018 Sep; 10(9):e3257. PubMed ID: 30416907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard].
    Bonnet U; Mahler H
    Fortschr Neurol Psychiatr; 2015 Apr; 83(4):221-31. PubMed ID: 25893495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
    Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
    Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
    Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
    Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Cannabinoid-Associated Multiple Organ Failure: Case Series and Literature Review.
    Armstrong F; McCurdy MT; Heavner MS
    Pharmacotherapy; 2019 Apr; 39(4):508-513. PubMed ID: 30811628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
    Tomiyama K; Funada M
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic cannabinoids: the hidden side of Spice drugs.
    Pintori N; Loi B; Mereu M
    Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review.
    Yeruva RR; Mekala HM; Sidhu M; Lippmann S
    Innov Clin Neurosci; 2019 Jan; 16(1-2):31-32. PubMed ID: 31037226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.